Search

Author/Creator Buti, Maria

71. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. (November 2016)

Authors:
Buti, Maria; Gane, Edward; Seto, Wai Kay; Chan, Henry L Y; Chuang, Wan-Long; Stepanova, Tatjana; Hui, Aric-Josun; Lim, Young-Suk; Mehta, Rajiv; Janssen, Harry L A; Acharya, Subrat K; Flaherty, John F; Massetto, Benedetta; Cathcart, Andrea L; Kim, Kyungpil; Gaggar, Anuj; Subramanian, G Mani; McHut...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 1:Number 3(2016)
Page Start:
196
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

72. Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml). (28th October 2014)

Authors:
Fung, Scott; Gordon, Stuart C.; Krastev, Zahary; Horban, Andrzej; Petersen, Jörg; Sperl, Jan; Gane, Edward; Jacobson, Ira M.; Yee, Leland J.; Dinh, Phillip; Martins, Eduardo B.; Flaherty, John F.; Kitrinos, Kathryn M.; Dusheiko, Geoffrey; Trinh, Huy; Flisiak, Robert; Rustgi, Vinod K.; Buti, Maria...
Journal:
Liver international
Issue:
Volume 35:Number 2(2015:Feb.)
Page Start:
422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

75. Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection. (10th July 2019)

Authors:
Marcellin, Patrick; Wong, David K; Sievert, William; Buggisch, Peter; Petersen, Jörg; Flisiak, Robert; Manns, Michael; Kaita, Kelly; Krastev, Zahari; Lee, Samuel S; Cathcart, Andrea L; Crans, Gerald; Op den Brouw, Marjoleine; Jump, Belinda; Gaggar, Anuj; Flaherty, John; Buti, Maria
Journal:
Liver international
Issue:
Volume 39:Number 10(2019)
Page Start:
1868
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

76. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Issue 10319 (1st January 2022)

Authors:
Karlsen, Tom H; Sheron, Nick; Zelber-Sagi, Shira; Carrieri, Patrizia; Dusheiko, Geoffrey; Bugianesi, Elisabetta; Pryke, Rachel; Hutchinson, Sharon J; Sangro, Bruno; Martin, Natasha K; Cecchini, Michele; Dirac, Mae Ashworth; Belloni, Annalisa; Serra-Burriel, Miquel; Ponsioen, Cyriel Y; Sheena, Bri...
Journal:
Lancet
Issue:
Volume 399:Issue 10319(2022)
Page Start:
61
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

77. The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries. (24th February 2021)

Authors:
Mennini, Francesco S.; Marcellusi, Andrea; Robbins Scott, Sarah; Montilla, Simona; Craxi, Antonio; Buti, Maria; Gheorghe, Liana; Ryder, Stephen; Kondili, Loreta A.
Journal:
Liver international
Issue:
Volume 41:Number 5(2021)
Page Start:
934
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗